IOBT / IO Biotech, Inc. - Institutional Ownership - Buyers

IO Biotech, Inc.
US ˙ NasdaqGS ˙ US4497781090

Institutional and Fund Ownership - Buyers

Major holders that have opened new positions in IO Biotech, Inc. include Marex Group plc, GWM Advisors LLC, Cubist Systematic Strategies, LLC, and Raymond James Financial Inc .

This page shows changes in the ownership structure by listing institutions, funds, and major shareholders that have increased their holdings or opened new positions in the last reporting period. Green rows indicate new positions. Click the link icon to see the full transaction history.

Upgradeto unlock premium data.

File Date Source Investor Type Avg Price
(Est)
Shares Δ Shares
(%)
Reported
Value
($1000)
Δ Value
(%)
Port Alloc
(%)
2025-08-14 13F Sectoral Asset Management Inc 117,691 23.89 164 58.25
2025-08-14 13F GWM Advisors LLC 24,217 34
2025-08-11 13F Citigroup Inc 314 0
2025-08-08 13F SBI Securities Co., Ltd. 132 1.54 0
2025-08-14 13F Jane Street Group, Llc 25,946 9.40 36 44.00
2025-08-14 13F UBS Group AG 13,259 7.32 18 38.46
2025-08-14 13F Raymond James Financial Inc 1,000 1
2025-08-19 13F Marex Group plc 45,000 63
2025-08-12 13F Proequities, Inc. 0 0
2025-08-14 13F Two Sigma Securities, Llc 10,385 14
2025-08-13 13F Renaissance Technologies Llc 139,300 10.21 194 40.88
2025-08-14 13F Cubist Systematic Strategies, LLC 13,096 18
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista